Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Primary Myelofibrosis × durvalumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 45 Lung Neoplasms 29 Carcinoma, Hepatocellular 20 Small Cell Lung Carcinoma 17 Urinary Bladder Neoplasms 12 Liver Neoplasms 10 Biliary Tract Neoplasms 10 Breast Neoplasms 8 Neoplasms 7 Stomach Neoplasms 5 Neoplasm Metastasis 5 Colorectal Neoplasms 5 Cholangiocarcinoma 5 Carcinoma, Transitional Cell 5 Triple Negative Breast Neoplasms 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Non-Muscle Invasive Bladder Neoplasms 4 Carcinoma 4 Squamous Cell Carcinoma of Head and Neck 3 Neoplasms by Site 3 Endometrial Neoplasms 3 Adenocarcinoma Of Esophagus 3 Adenocarcinoma 3 Thoracic Neoplasms 2 Respiratory Tract Neoplasms 2 Respiratory Tract Diseases 2 Pathologic Complete Response 2 Oropharyngeal Neoplasms 2 Mouth Neoplasms 2

Interventions

ruxolitinib 11 fludarabine 5 Tacrolimus 5 Stem Cell Transplantation 5 Specimen Handling 5 Cyclophosphamide 5 Whole-Body Irradiation 4 fludarabine phosphate 3 Mycophenolic Acid 3 Busulfan 3 venetoclax 2 selinexor 2 navitoclax 2 Peripheral Blood Stem Cell Transplantation 2 Melphalan 2 Granulocyte Colony-Stimulating Factor 2 Decitabine 2 Blood Component Removal 2 Biopsy 2 Azacitidine 2 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2 veliparib 1 piperine 1 pevonedistat 1 pegylated granulocyte colony-stimulating factor 1 merphos 1 letermovir 1 iadademstat 1 fedratinib 1 demethoxycurcumin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡